Spironolactone After Liver Transplant

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Transplant, Liver

Interventions

DRUG

Spironolactone

spironolactone 25 mg up to 50 mg

Trial Locations (1)

CHS, Charlotte

All Listed Sponsors

lead

Wake Forest University Health Sciences

OTHER

NCT02883400 - Spironolactone After Liver Transplant | Biotech Hunter | Biotech Hunter